Long-term treatment with nipradilol, a nitric oxide-releasing β-adrenergic blocker, enhances postischemic recovery and limits infarct size

Annals of Thoracic Surgery

Volumn 73, Issue 1, 2002, Pages 173-179

  Suematsu, Yoshihiro ^a   Ohtsuka, Toshiya ^b   Horimoto, Hitoshi ^b   Maeda, Katsuhide ^b   Nakai, Yasunari ^b   Mieno, Shigetoshi ^b   Takamoto, Shinichi ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NIPRADILOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART HEMODYNAMICS; HEART INFARCTION PREVENTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LIPID PEROXIDATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PROPANOLAMINES; RATS; RATS, WISTAR; VENTRICULAR FUNCTION, LEFT; VENTRICULAR PRESSURE;

EID: 0036149743     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)03234-9     Document Type: Article

References (31)

1. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy 3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent
2. The beta adrenoreceptor antagonist, nipradilol, preserves the endothelial nitric oxide response in atherosclerotic vessels of rabbit
3. Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation
4. Chronic treatment with propranolol induces antioxidant changes and protects against ischemia-reperfusion injury
5. Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: A novel mechanism of action of beta-blockers
6. Protective effect of pretreatment with verapamil, nifedipine and propranolol on mitochondrial function in the ischemic and reperfused myocardium
7. Nitric oxide-generating beta-adrenergic blocker nipradilol preserves postischemic cardiac function
8. Pharmacokinetics of nipradilol (K-351), a new anti-hypertensive agent. I. Studies on interspecies variation in laboratory animals
9. Cardiovascular effects of nipradilol, a beta-adrenoceptor blocker with vasodilating properties
10. Normothermic transfer times up to 3 min will not precondition the isolated rat heart
11. L-Arginine given after ischaemic preconditioning can enhance cardioprotection in isolated rat hearts
12. Inhibition of nitric oxide synthase and soluble guanylate cyclase induces cardiodepressive effects in normal rat hearts
13. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size
14. Cyclic GMP elevation by 5-hydroxytryptamine is due to nitric oxide derived from endogenous nitrosothiol in NG108-15 cells
15. Correlation between antioxidant changes during hypoxia and recovery on reoxygenation
16. 4-induced contraction in guinea pig tracheal smooth muscle
17. Cyclic GMP regulates the Ca-channel current in guinea pig ventricular myocytes
18. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system
19. The role of nitric oxide in cardiac ischemia-reperfusion injury
20. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium
21. Ischemic preconditioning slows energy metabolism and delays ultra-structural damage during a sustained ischemic episode
22. Ischemic preconditioning against arrhythmias: An anti-arrhythmic or an anti-ischemic phenomenon?
23. + channel
24. Pharmacologic preconditioning induced by beta-adrenergic stimulation is mediated by activation of protein kinase C
25. Ischemic preconditioning and the beta-adrenergic signal transduction pathway
26. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system
27. Adenosine-enhanced ischemic preconditioning provides enhanced postischemic recovery and limitation of infarct size in the rabbit heart
28. Adenosine-enhanced ischemic preconditioning provides enhanced cardioprotection in the aged heart
29. Comparison of ischemic vulnerability and responsiveness to cardioplegic protection in crystalloid-perfused versus blood-perfused hearts
30. The L-arginine-nitric oxide pathway
31. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts